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Abstract 
During the transition to extra-uterine life preterm infants are at high risk of developing 
circulatory failure. Currently hypotension is used as major diagnostic criteria for 
starting treatments such as fluid boluses, inotropes or steroids. Most of these 
treatment options have not been studied in large randomised controlled trials for 
efficacy and safety and are under discussions. A wide variety in their use is reported 
in the literature and clear evidence about which inotrope or other treatment should 
be preferred is lacking. In addition there is on-going debate about the appropriate 
threshold values for blood pressure. Other diagnostic measures for poor circulation 
are functional echocardiography, near-infrared spectroscopy, capillary refill time, 
base excess and serum lactate. Large randomised controlled trials for the use of 
dopamine and dobutamine in preterm infants < 32 weeks gestation are under way to 
fill the knowledge gaps on the assessment of circulatory compromise and on efficacy 
and safety of the studied age appropriate drug formulations. 
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Introduction 
The first three days after birth represent a unique period in human life as the anatomy 
and dynamics of the circulatory system change for adaptation to extrauterine life. The 
foetal channels of open foramen ovale and patent ductus arteriosus normally close 
within the first day of life in term infants ,(1). 
After clamping the umbilical cord, the first inflation breaths of the lungs and the 
associated increase in arterial oxygen content are accompanied by an increase in 
systematic vascular resistance resulting in increased afterload and a decrease in 
pulmonary vascular resistance leading to increased pulmonary blood flow. These 
haemodynamic changes are specific to the transition after birth and failure to adapt can 
lead to unique clinical challenges, (1). 
 
Circulatory transition in preterm infants 
Preterm infants born before 32 weeks gestation are at increased risk of failing to 
adapt to the circulatory changes after birth and thus will develop early 
haemodynamic insufficiency, (2, 3, 4). Compared to term infants myocytes are less 
well developed before 32 weeks gestation. Due to immature receptors the autonomic 
nervous system is less active and less responsive to stimuli in preterm infants. This 
leads to a reduced reserve of ventricular contractility of the heart which is less able 
to distend its ventricles thereby affecting the preload. An open ductus arteriosus 
often provides additional strain to the heart function through either bidirectional or 
left-to-right shunting.  Preterm infants might be able to compensate for the increased 
preload through high systemic vascular resistance with normal blood pressure. 
However poor myocardial contractility can lead to low systemic blood flow and a 
decompensated stage at which hypotension might occur. About 80% of the infants 
who develop low systemic blood flow will subsequently develop systemic 
hypotension ,(5). 
Challenges in diagnosing circulatory failure in preterm infants  
 
In current clinical practice infants born at less than 32 weeks´ gestation are routinely 
monitored for changes in vital parameters such as heart rate, systolic, mean and 
diastolic blood pressure and capillary refilling time ,(6, 7, 8, 9).  
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Challenges in blood pressure measurements  
Preference is given to non-invasive methods of measuring blood pressure unless the 
infants have indwelling umbilical catheters so that it can be measured invasively. A 
prospective cohort study in 50 preterm infants of 24 to 32 weeks´ gestation comparing 
non-invasive oscillometric blood pressure measurements with those obtained via 
indwelling arterial lines demonstrated a good relation between both methods during the 
first 24 h of life ,(10). However the first method cannot be used continuously, depends 
on the correct cuff size, it is problematic in very low birth weight infants and not as 
reliable as the second invasive method, (11,12).  The traditionally used thresholds for 
blood pressure in preterm and term infants are based on studies done more than 3 
decades ago, (13, 14). Attempts have been made to update these values with 
statistically defined normal values, (15, 16). Discussions are ongoing to decide whether 
these values describe a normal blood pressure range at which organ perfusion is 
maintained in particular for very low birth weight infants. The published reports vary 
with regard to investigating the relationship between low blood pressure, its treatments 
and long term neurodevelopmental outcome, (2, 5). A recent cohort study on 4907 
preterm infants with a birth weight < 1500 g reported median values and interquartile 
ranges for the lowest mean arterial blood pressure during the first 14 h of life and by 
gestational age ,(17). The authors report that infants with blood pressure values below 
their median minimum blood pressure and who did not receive treatment with 
vasoactive medication had a higher incidence of intra-ventricular haemorrhage, 
broncho-pulmonary dysplasia or death. 
 
 Functional echocardiography  
Due to the outlined problems with blood pressure other measures of cardiac function 
assessed by functional echocardiography using Doppler are being used to assess 
circulatory failure. Superior vena cava flow together with right and left ventricular output 
measurements have been used in preterm infants. Left ventricular output has been 
validated against the gold standard of determining cardiac outputs according to the 
Fick principle, using measured oxygen consumption calculated oxygen capacity, and 
oxygen saturation, in small cohorts of newborn infants and children ,(18, 19). 
In comparison to left and right ventricular output superior vena cava flow measured by 
echocardiography Doppler method is not influenced by the open foetal channels. It 
represents the portion of systemic blood flow from the upper body including the brain, 
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which is thought to be 70-80% in newborn infants ,(20). A study of 27 preterm infants 
showed a good correlation of superior vena cava flow with cerebral tissue oxygenation 
index used as a marker of cerebral blood flow and measured by near-infrared 
spectroscopy, (21). Several studies in preterm infants have demonstrated that low 
superior vena cava flow is associated with surrogate markers of poor outcome ,(22, 23, 
24). Kluckow et al studied 126 babies born before 30 weeks’ gestation of whom 48 
(38%) had low superior vena cava (SVC) flow (< 41 ml/kg/min) within 24 hours of birth, 
,(24).  Fourteen infants (11%) developed significant intra-ventricular haemorrhage more 
than 6 hours after birth: 13/14 were in the low SVC flow group and 1/14 was in the 
normal SVC flow group.  In another study Miletin et al studied 40 preterm infants, eight 
(20%) of whom had low SVC flow within 24 hours of birth ,(25).  The incidence of a 
composite outcome of intra-ventricular haemorrhage and/or death was 4/8 (50%) 
among neonates with low superior cava flow and 2/32 (7%) among neonates with 
normal flow. Two recent studies have demonstrated an association between low 
superior vena cava flow and adverse outcomes using multivariate analysis: mortality 
,(26) or severe ischemic events as an indication of impaired blood flow distribution 
,(27). Based on the recent interest in echocardiography assessment in the early 
neonatal period guidelines and recommendation for training neonatologists in this 
bedside technique have been developed ,(28, 29). 
 
Capillary refill time as a marker of circulatory perfusion 
Other surrogate markers of circulatory perfusion failure described in the literature are 
capillary refill time and serum lactate. 
Capillary refill time is used by clinicians as a proxy of cardiac output and systemic 
vascular resistance in newborn infants. The technique can be used at the bedside 
during normal clinical care but depends on variables such as skin site tested and 
pressure duration. Inter-observer variability can be wide and influencing factors might 
be ambient temperature, concomitant medications, and maturation-dependent skin 
blood flow regulation. There is a weak correlation between capillary refill time and 
markers of systemic perfusion both in the paediatric and in the neonatal population ,( 9, 
30). A capillary refill time of 3 sec had a sensitivity of 55% and specificity of 80% for 
low superior vena cava flow. A cut off for capillary refill time of 4 sec increased the 
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specificity to 96% but reduced the sensitivity to 29%. The area under the ROC was 
0.72 (95% CI 0.64 to 0.8) ,(30). 
 
Studies have been performed to combine biomarkers in order to better describe 
circulatory failure in newborn infants. When combining thresholds for mean blood 
pressure <30mmHg and/or capillary refill time  3 sec this had a similar diagnostic 
accuracy to a systolic blood pressure <40mmHg with 78% sensitivity, 63% specificity, 
positive predictive value 31% and negative predictive value 88% ,(30). 
 
Serum lactate as a biomarker of tissue perfusion 
Serum lactate as an additional biochemical marker of decreased tissue perfusion 
acidosis has not been systematically analysed in newborn infants. A study in ventilated 
infants found a poor correlation between base excess and blood lactate levels ,(31). 
More recently, a strong correlation between serum lactate and base excess has been 
reported in preterm infants in the transition period after birth.  A single serum lactate 
above 5.6 mmol/L showed a high sensitivity and specificity to indicate adverse outcome 
in preterm infants on the first day of life ,(32). These studies did not include systematic 
evaluation of other haemodynamic parameters such as blood pressure, cardiac output 
or capillary refill time.  Hypotensive infants who receive cardiovascular treatment with 
epinephrine have shown to increase their serum lactate levels despite normalising their 
blood pressure and improving their cerebral blood flow measured by near infrared 
spectroscopy (33, 34); this effect might be caused by increased gluconeogenesis and 
glucogenolysis due to epinephrine stimulation of the peripheral beta-2 receptors. 
A recent study of preterm infants observed an association of lactate > 4 mmol/L in the 
first 12 hours of life with the combined adverse outcome of death or severe brain injury 
,(35). 
 
Treatment options of circulatory failure 
A few studies have measured plasma catecholamines in preterm and term babies 
during the first hours of life, (36, 37, 38, 39). Babies born after “normal” birth showed 
a rapid decline of catecholamine levels measured in umbilical arterial blood from 
immediately at delivery to 48 h after birth. All studies report lower plasma levels for 
premature infants due to the immature function of the adrenal glands. 
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Thus it seems reasonable to treat preterm infants with hypotension with inotropes 
such as dopamine, dobutamine, adrenaline or noradrenaline. They have been used 
since many years in spite of the immature receptors in preterm infants. Guidelines 
and recommendations for treatment pathways have been widely published and vary 
in their recommendations ,(40, 41, 42, 43). Discussions remain on which inotropes to 
use and whether their use is associated with increased morbidity and mortality ,(44). 
Dopamine and dobutamine have not been studied in large randomised controlled 
trials in preterm infants ,(44, 45). 
Survey of inotrope use 
In a recent large international survey on the diagnosis and management of 
hypotension in preterm infants Stranak at al ,(46) were able to collect data from 216 
neonatal units around the world. More than 85% of centres use a fluid bolus of 10 
ml/kg cystalloid solution as the first step to treat hypotension. Fifty-nine percent of 
centres would follow this up by a second fluid bolus and 14% by a third before 
starting inotropes. Dopamine as a first line treatment was used by 80% of the 
centres, of whom 18% combined it with dobutamine. There was great variation in the 
reported use for second line treatment such as dobutamine alone or in combination 
with dopamine, epinephrine, norepinephrine, steroids or milrinone.  
Combining biomarker for drug efficacy assessments 
The authors of the international survey were able to get data on preferred use of 
clinical and laboratory data used for the assessment of hypotension and poor 
perfusion in preterm infants ,(46). High priority was reported for capillary refill time, 
urine output, heart rate, peripheral skin colour, base excess and lactate values. 
Additional investigations for cardiac function were used to measure left and right 
cardiac output, fractional shortening of left ventricle and superior vena cava flow. A 
smaller proportion of neonatal centres used other additional assessment such as 
perfusion index,  aEEG or near infra-red spectroscopy and relationship with 
neurodevelopmental outcomes ,(33, 34, 47, 48). 
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Extra placental blood influences postnatal circulatory adaptation 
Delayed cord clamping enhances the transfer of placental blood to the baby at birth 
and 51% of the centres reported routine use in preterm infants. A Cochrane review 
,(49) on the effects of delayed cord clamping in preterm infants reported benefits of 
higher blood pressure in the first days of life, less need for volume therapy or 
inotropes as short term outcomes and less need for blood transfusions. A recent 
meta-analysis for preterm infants < 30 weeks gestation and <1000 g birth weight 
confirmed these benefits for this very high risk group ,(50). Few studies on longer 
neurodevelopmental outcome have ben published but significant harm of delayed 
cord clamping has not been identified yet ,(50).  Milking (gentle stripping) of the 
umbilical cord towards the infant has been studied as an alternative method of 
providing extra placental blood in a short time to the infants. Two studies comparing 
delayed cord clamping of 30 or 60 seconds with 4 times milking of the cord in 
preterm infants < 32 weeks showed similar patterns for increasing blood pressure 
during the first week of life in both groups with very low need for inotrope treatment 
,(51, 52). A neurodevelopmental follow-up study at 3.5 years corrected age showed 
no difference for both groups in the first comparison study ,(53). In January 2017 the 
large Australian Placental transfusion Study has completed enrolling more than 1600 
preterm infants into a randomized controlled trial of comparing immediate with 
delayed cord clamping of more than 60 seconds, (54). The data from this study will 
significantly enhance the knowledge on this simple intervention. 
The need for clinical studies 
The need for large clinical studies on the use of dopamine and dobutamine has been 
prioritized by the European Commission and the European Medicines Agency and 
therefore funding was made available under the Seventh Framework Programme for 
Health.  
The HIP trial 
The HIP consortium ,(55) is currently studying an age appropriate formulation of 
dopamine in preterm infants from 23 weeks to 27 weeks and 6 days gestational age 
during the first 72 hours of life, (44). Infants can be enrolled into a randomised 
controlled trial if they meet the inclusion criteria with a mean blood pressure 
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measured by indwelling arterial line of 1 mmHg or more below a mean blood 
pressure value equivalent to the gestational age in weeks. Infants with intra-
ventricular haemorrhage grade III or IV on cerebral ultrasound, life threatening 
congenital abnormalities or who are classed as non-viable are excluded. Infants will 
be randomised to receive a fluid bolus of 10 ml/kg of normal saline followed by either 
Dopamine started at 5 μg/kg/min with a maximum dose increase up to 20 μg/kg/min 
or normal saline as placebo in an equivalent amount of infusion volume. In addition 
thresholds for capillary refill time > 4 s and lactate > 4 mmol/L will be used to assess 
the need for further inotrope treatment.as per local guidelines. Subgroups of infants 
will be assessed for evaluation of end-organ perfusion by measuring cardiac out put 
(right and left ventricular output, superior vena cava flow). Near-infrared 
spectroscopy will be used to measure cerebral oxygenation and continuous multi-
channel EEG to study the effects of mean blood pressure changes on cerebral 
electrical activity in selected centres. Primary outcome measures are survival without 
significant brain injury at 36 weeks´ postmenstrual age and survival without 
neurodevelopmental disability at 2 years of age corrected for prematurity ,(44). 
The NEO-CIRC trials 
The NEO-CIRC consortium ,(56, personal communication) has taken a similar 
approach to study an age appropriate formulation of dobutamine. After completion of 
a pilot exploratory study (unpublished data) the consortium is currently setting up a 
randomised controlled trial similar to the HIP-Trial in preterm infants between 24 and 
32 weeks gestation who develop signs of circulatory failure during the first 72 h after 
birth. It is hoped that by the end of both studies the international community will be 
able to develop a new consensus on the definition of neonatal circulatory failure for 
preterm infants in the transition period after birth. The studies will hopefully 
contribute to the availability of age appropriate licensed inotropes for this age group. 
Recommendations for research 
An international consensus on a definition of circulatory failure in the transition period 
is urgently required. Large randomised controlled trials are under way to provide 
evidence on efficacy and safety of dopamine and dobutamine in the treatment of 
hypotension of preterm infants. Future studies in this field should take other 
measures than blood pressure alone and surrogate biomarkers for tissue perfusion 
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such as functional echocardiography, capillary refill time, base excess and lactate 
levels into account. Enhanced placental transfusion at birth either by delayed cord 
clamping or milking of the cord can be the start of preventative measures of 
hypotension. Information about its use should be recorded in all future studies. An 
international agreement about valid thresholds for treating low or high blood pressure 
in the newborn period is urgently required. The Haemodynamics Working Group of 
the International Neonatal Consortium hosted by the Critical Path Institute is 
currently working on a consensus, (57). 
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